Signal2026-08-12
ClinicalTrials.gov

[PHASE1] A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceRead on Substack